Distribution of Technological Competencies in the Field of the Antidiabetic Drugs Development in the Regions of the Russian Federation
DOI:
https://doi.org/10.17059/2019-4-10Keywords:
Russian pharmaceutical market, technological competence, regional competence profile, patent landscapeAbstract
The high level of uncertainty in the Russian pharmaceutical competitive environment creates a necessity of using open data that indicate the degree of the organizations’ technological competencies. The Analysis of the information on the organizations’ localization in the regions allows generating a regional competence profile, which can be used to plan the drugs’ production. The study aims to analyse the distribution of technological competencies in the Russian regions by assessing the prospects for locating production sites of foreign and Russian organizations specialising in the antidiabetic drugs development. We hypothesise that the analysis of the distribution of technological competencies in the regions reduces the market’s uncertainty for deciding on the localization of the socially significant industries. The research model is based on the methods of average-weighted, ranking and categorical analysis of the patent and registration data for shaping the regional competence profiles. The implementation of this method of analysing the organizations’ technological competencies is showed on the example of 18 regions that have production sites of antidiabetic drugs. We substantiated the allocation of 5 types of regional profiles, characterised by similar opportunities and threats for new participants in the pharmaceutical market. We revealed that the model of the cooperation behaviour should consider the technological profile at the regional level. At the same time, the model of competitive behaviour to a much lesser extent depends on the regional characteristics of localized production. The methods of constructing the regions patent and product ratings and their categorization (with allocation of typical behaviour models) allow determining the technological opportunities for increasing the availability and quality of the Russian pharmaceutical products. Moreover, such methods allow identifying the prospects for long-term cooperation with technological leaders at the regional and industrial levels. That is especially important for implementing the concept of the national drug safety and increasing the availability of the socially significant drugs.References
Dubois, P., Mouzon, O., Scott‐Morton, F. & Seabright, P. (2015). Market size and pharmaceutical innovation. The RAND Journal of Economics, 46(4), 844–871. DOI: https://doi.org/10.1111/1756–2171.12113.
Branstetter, L., Chatterjee, C. & Higgins, M. J. (2016). Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry. The RAND Journal of Economics, 47(4), 857–890. DOI: https://doi.org/10.1111/1756– 2171.12157.
Grabowski, H. (2004). Are the economics of pharmaceutical research and development changing? Productivity, patents and political pressures. Pharmacoeconomics, 22(2), 15−24. DOI: 10.2165/00019053–200422002–00003.
Coccia, M. (2017). Sources of technological innovation: Radical and incremental innovation problem-driven to support competitive advantage of firms. Technology Analysis & Strategic Management, 29(9), 1048−1061.
Nikolopoulos, K., Khammash, M., Buxton, S. & Stern, P. (2016). Forecasting branded and generic pharmaceuti- cals. International Journal of Forecasting, 32(2), 344−357.
Jekunen, A. (2014). Decision-making in product portfolios of pharmaceutical research and development — managing streams of innovation in highly regulated markets. Drug Design Development and Therapy, 8, 2009–2016. DOI: 10.2147/ DDDT.S68579.
Ivanov, N. I. & Foukova, D. Yu. (2009). Konkurentnyy analiz: benchmarking [Benchmarking vs. Competitive analysis]. Ekonomicheskiy analiz: teoriya i praktika [Economic analysis: theory and practice], 22, 53−55. (In Russ.)
Kadirov, E. A. (2018). Primenenie benchmarketinga kak innovatsionnoy marketingovoy tekhnologii na farmatsevticheskom rynke [Benchmarking as an innovative marketing technology on the pharmaceutical market]. Obshchestvo: Politika, ekonomika, pravo [Society: Politics, Economics, Law], 2, 29−33. (In Russ.)
Dahooie, H., Zavadskas, E. K., Firoozfar, H. R., Vanaki, A. S., Mohammadi, N. & Brauers, W. K. M. (2019). An im- proved fuzzy MULTIMOORA approach for multi-criteria decision making based on objective weighting method (CCSD) and its application to technological forecasting method selection. Engineering Applications of Artificial Intelligence, 79, 114−128.
Dirnberger, D. (2011). A guide to efficient keyword, sequence and classification search strategies for biopharmaceu- tical drug-centric patent landscape searches — A human recombinant insulin patent landscape case study. World Patent Information, 33, 128−143.
Lee, Ch., Kwon, O., Kim, M. & Kwon, D. (2018). Early identification of emerging technologies: A machine learning approach using multiple patent indicators. Technological Forecasting & Social Change, 79, 291–303.
Huang, C., Lin, H. H., Wan, J., He, C. & Hu, Y. (2016). Research and Development of Hepatitis B Drugs: An Analysis Based on Technology Flows Measured by Patent Citations. PLoS One, 11(10), 1−17. DOI: 10.1371/journal.pone.0164328.
Pereira, C. G., Lavoie, J. R., Garces, E., Basso, F., Dabićc, M., Portoa, G. S. & Daimb, T. (2019). Forecasting of emerging therapeutic monoclonal antibodies patents based on a decision model. Technological Forecasting & Social Change, 139, 185–199.
Fabry, B., Ernst, H., Langholz, J. & Koster, M. (2006). Patent portfolio analysis as a useful tool for identifying R&D and business opportunities — an empirical application in the nutrition and health industry. World Patent Information, 28, 215–225.
Kumar P. (2018). Patent research as a key strategy tool. Pharm Exec Magazine, 9. Retrieved from: http://www. pharmexec.com/patent-research-key-strategy-tool (Date of access: 10.01.2019).
Song, C. H. & Han, J.-W. (2016). Patent cliff and strategic switch: exploring strategic design possibilities in the phar- maceutical industry. Springerplus, 5(1), 692. DOI: 10.1186/s40064–016–2323–1.
Yu, X. & Zhang, B. (2017). Obtaining advantages from technology revolution: A patent roadmap for competition analysis and strategy planning. Technological Forecasting & Social Change, 11. DOI: http://dx.doi.org/10.1016/j.tech-fore.2017.10.008.
Hsueh, C.-C. & Chen, D.-Z. (2015). A taxonomy of patent strategies in Taiwan’s small and medium innovative enterprises. Technological Forecasting & Social Change, 92, 84–98.
Milanez, D. H., Faria, L. I. L., Amaral, R. M. & Gregolin, J. A. R. (2017). Claim-based patent indicators: A novel ap- proach to analyze patent content and monitor technological advances. World Patent Information, 50, 64−73.
Tikhanov, E. А, Krivorotov, V. V. & Chepur, P. V. (2016). Analiz i sistematizatsiya metodov otsenki konkurentosposobnosti [Analysis and systematisation of enterprises competitiveness evaluation methods]. Fundamentalnye issledovaniya [Fundamental research], 10(3), 647–651. (In Russ.)
Grek, P. V. (2007). Primenenie marketingovykh instrumentov v usloviyakh kategoriynogo menedzhmenta [Marketing assessment application in the field of category management]. Remedium, 1, 27−30. (In Russ.)
Grishin, A. V. & Krasheninin, A. N. (2010). Innovatsionnaya Sistema upravleniya tovarnymi zapasami aptechnoy organizatsii [Drug stocks management: innovative system]. Novaya apteka [New Pharmacy], 8, 10−15. (In Russ.)
Parnell, J. A., Long, Z. & Lester, D. (2015). Competitive strategy, capabilities and uncertainty in small and medium sized enterprises (SMEs) in China and the United States. Management Decision, 53(2), 402–431. DOI: https://doi. org/10.1108/MD-04–2014–0222.
Koufteros, X. A., Vonderembse, M. A. & Doll, W. J. (2002). Integrated product development practices and competitive capabilities: the effects of uncertainty, equivocality, and platform strategy. Journal of Operations Management, 20(4), 331–355. DOI: 10.1016/S0272–6963(02)00018–9.
Azzaro-Pantel, C. (2018). New Product Development and Supply Chains in the Pharmaceutical Industry. Computer Aided Chemical Engineering, 41, 1−26.
Marques, C. M., Moniz, S. & Sousa, J. P. (2018). Strategic decision-making in the pharmaceutical industry: A unified decision-making framework. Computers & Chemical Engineering, 119, 171−189.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Sergey Vsevolodovich Kortov, Dmitry Borisovich Shulgin, Aleksey Vladimirovich Rodnin, Alisa Alekseevna Karimova
This work is licensed under a Creative Commons Attribution 4.0 International License.
